FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)

View source ↗

Summary

The FDA approved a supplemental application for furosemide from Phlow Corporation, authorizing an additional or revised approval for the diuretic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Edema
• Heart Failure
• Hypertension
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)